This week, while most eyes in the biotech world were on the IPO of gene therapy firm Voyager Therapeutics, an early-stage drug developer called WaVe Life Sciences pulled off an even larger IPO on the other side of Cambridge. Wave (Nasdaq: WVE), a biotech with corporate offices in Alewife but based in Singapore, managed to raise $102 million on Wednesday, the same day that Voyager (Nasdaq: VYGR) was raising $70 million.

Topics:  voyager therapeutics   wave life sciences   cambridge   wave nasdaq   wve    alewife   singapore   voyager nasdaq   vygr    sec   ipo   biotech   led   million   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News